ClearPoint Neuro, Inc. CLPT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.46M | -11.34M | -9.55M | -7.79M | -5.89M |
| Total Depreciation and Amortization | 1.33M | 1.08M | 816.00K | 752.00K | 426.00K |
| Total Amortization of Deferred Charges | 357.00K | 350.00K | 339.00K | 122.00K | 39.00K |
| Total Other Non-Cash Items | 1.85M | 2.77M | 2.65M | 2.20M | 2.34M |
| Change in Net Operating Assets | -1.18M | 122.00K | -2.22M | -7.37M | -35.00K |
| Cash from Operations | -5.11M | -7.02M | -7.97M | -12.08M | -3.12M |
| Capital Expenditure | -137.00K | -214.00K | -645.00K | -49.00K | -199.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 1.14M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -137.00K | -214.00K | -645.00K | 1.09M | -199.00K |
| Total Debt Issued | -- | -- | -- | 19.43M | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 22.07M | 1.00M | 148.00K | 326.00K | 0.00 |
| Repurchase of Common Stock | 0.00 | 0.00 | -1.99M | -195.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 22.07M | 1.00M | -1.85M | 19.56M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.82M | -6.23M | -10.46M | 8.57M | -3.32M |